Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of Grazax with antihistamine in grass pollen-induced rhinoconjunctivitis
2008-003593-18Phase 3Completed
- Sponsor
- ALK-Abelló
- Start
- Jul 2008
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in allergic rhinoconjunctivitis (ARC) comparing Grazax + Aerius with Grazax + placebo (2 arms). Started Jul 2008; status: completed.
02
Drugs
phleum pratense allergen extract
03
Conditions
allergic rhinoconjunctivitis (ARC)
Beyond the preview
Go deeper on 2008-003593-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003593-18.